Australia markets open in 1 hour 6 minutes

Koninklijke Philips N.V. (PHG)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
53.63-0.56 (-1.03%)
At close: 4:00PM EST

54.00 +0.37 (0.69%)
After hours: 4:18PM EST

Full screen
Trade prices are not sourced from all markets
Previous close54.19
Open53.65
Bid53.71 x 900
Ask53.69 x 1100
Day's range53.53 - 54.13
52-week range30.50 - 58.41
Volume583,812
Avg. volume435,353
Market cap48.314B
Beta (5Y monthly)0.69
PE ratio (TTM)33.94
EPS (TTM)1.58
Earnings dateN/A
Forward dividend & yield1.03 (1.93%)
Ex-dividend date10 May 2021
1y target est57.00
  • Philips Incisive CT gets even smarter with debut of AI-enabled Precise Suite
    GlobeNewswire

    Philips Incisive CT gets even smarter with debut of AI-enabled Precise Suite

    Philips Incisive CT in use with patient Philips Incisive CT in use by tech operator Precise Suite Incisive carotid Precise Suite Incisive cardiac March 4, 2021 New Precise Suite on the Philips Incisive CT platform accelerates CT workflows to help drive diagnostic confidence and improve the patient and staff experience Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of its AI-enabled Precise Suite [1] solution for the company’s Incisive CT platform. Precise Suite delivers smart workflows from image acquisition through reporting with AI-enabled image reconstruction, automated patient positioning, motion-free cardiac image capture, and real-time interventional guidance to drive precision in dose, speed, and image quality. Despite rapid advances in Computed Tomography (CT) speed and performance, radiology departments continue to face challenges in terms of increasing patient volumes and ensuring consistency in image quality, while at the same time improving operational efficiency and lowering the cost-per-scan. Precise Suite aims to address these challenges through the use of artificial intelligence (AI) [2] to streamline and automate workflows and maximize image quality, thereby reducing the number of re-scans required and improving diagnostic confidence. For departments that use CT for interventional procedures, it also includes enhanced needle tracking capabilities. “With CT representing one of the most ubiquitous imaging modalities in modern medicine, AI-enabled enhancements such as Precise Suite that focus on diagnostic confidence and workflow improvement have huge potential to make a positive impact on the delivery of value-based healthcare,” said Karim Boussebaa, General Manager of Computed Tomography at Philips. “Precise Suite drives end-to-end smart workflows from image acquisition through to reporting, as well as boosting speed, consistency, and diagnostic confidence.” Precise Suite adds to Philips’ growing suite of AI-enabled ‘smart workflow’ solutions designed to support system operators at the point of image acquisition for greater efficiency. Precise Suite accelerates CT workflows, improves diagnostic confidence, and enhances the staff and patient experience through the following: Precise Image: Designed to improve diagnostic confidence and reduce radiologist fatigue by simultaneously reducing dose and improving image quality.Precise Position: Automated patient positioning through an AI-enabled camera designed to increase positioning accuracy and user-to-user consistency in a fraction of the time.Precise Cardiac: Zero-click technique designed to improve high heart rate cardiac imaging by compensating for cardiac motion.Precise Intervention: Provides automatic needle tracking and guidance designed to improve efficiency and confidence in CT-guided interventional procedures. Precise Suite is the latest in a continuous program of performance enhancements for Philips’ market-leading Incisive CT platform, which already includes a newly designed patient table that accommodates bariatric patients, the ‘Tube for Life’ guarantee, Philips’ PerformanceBridge process improvement services, and its DoseWise Portal patient/staff radiation exposure tracking solution. The inclusion of the AI-enabled Precise Suite combined with OnPlan patient-side controls and the ‘Tube-for-Life’ guarantee in a single CT scanner platform make Incisive CT unique in the industry. Precise Suite on Incisive CT is being unveiled at the 2021 European Congress of Radiology (ECR) virtual exhibition (March 3-7, 2021). For more information on Philips’ new portfolio of diagnostic and interventional solutions and AI-enabled applications to enhance radiology workflows at ECR 2021, visit www.philips.com/ecr and follow @PhilipsLiveFrom for #ECR2021 updates throughout the event. [1] Precise Suite is considered work in progress and is not CE marked and not available for sale.[2] According to the definition of AI from the EU High-Level Expert Group. For further information, please contact: Kathy O’ReillyPhilips Global Press OfficeTel.: +1 978-221-8919E-mail : kathy.oreilly@philips.comTwitter: @kathyoreilly Mark GrovesPhilips Global Press OfficeTel.: +31 631 639 916E-mail: mark.groves@philips.com About Royal Philips Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2020 sales of EUR 19.5 billion and employs approximately 82,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter. Attachments Philips Incisive CT in use with patient Philips Incisive CT in use by tech operator Precise Suite Incisive carotid Precise Suite Incisive cardiac

  • Philips advances AI-enabled streamlined workflow solutions in diagnostic X-ray at ECR 2021
    GlobeNewswire

    Philips advances AI-enabled streamlined workflow solutions in diagnostic X-ray at ECR 2021

    Philips Digital Radiography and Fluoroscopy system (CombiDiagnost R90) Philips Digital Radiography and Fluoroscopy system (CombiDiagnost R90) in use March 4, 2021 New partnership with AI software provider Lunit to incorporate its chest detection suite into Philips’ diagnostic X-ray suiteLatest release of Philips Digital Radiography and Fluoroscopy system (CombiDiagnost R90) receives FDA 510(k) clearance Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a partnership to incorporate the Lunit INSIGHT CXR chest detection suite into Philips’ diagnostic X-ray suite, during the European Congress of Radiology (ECR) virtual event (March 3-7, 2021). The partnership is one of the latest extensions of Philips’ AI-enabled portfolio of solutions in precision diagnosis, which leverages the company’s and third-party AI solutions to deliver optimized workflows that empower providers, patients, and administrators to turn data into actionable insights and drive the right care in the right sequence at the right time. At ECR Philips also announced that its Digital Radiography and Fluoroscopy system (CombiDiagnost R90) has received FDA 510(k) clearance. “For most patients, X-ray is the first diagnostic imaging step on their path to a definitive diagnosis,” said Daan van Manen, General Manager for Diagnostic X-ray at Philips. “Radiology departments and their technologists are continually under pressure. With simpler and more efficient workflows we can reduce variability and staff workload, increase productivity, and enhance patient experience. Our partnership with Lunit to incorporate their diagnostic AI into our X-ray suite combines with a host of intelligent and streamlined workflow features in the Philips Radiography Unified User Interface (Eleva) across our digital radiography systems, enabling a smooth and efficient, patient-focused workflow. This is another step in contributing to providing a path to precision diagnosis.” Lunit INSIGHT CXR chest detection suite accurately detects 10 of the most common findings in a chest X-ray, supports tuberculosis screening, and has shown clinical efficiency for detecting pneumonia, which can be an initial indication of COVID-19. By prioritizing cases with abnormality scores and facilitating fast triage of normal cases, the suite allows radiologists to focus on reading the abnormal cases. “By partnering with Philips, a major player in diagnostic X-ray, our AI will be available to its significant global installed base,” said Brandon Suh, CEO of Lunit. “We look forward to collaborating together as we work towards our ambition to make data-driven medicine the new standard of care. Lunit will continue to build upon its current AI offering, making it better and better with time, and will continue to deliver best-in-class AI.” Through breakthrough innovation and partnerships, Philips continues to integrate intelligence and automation into its Precision Diagnosis portfolio. This includes its smart diagnostic systems, integrated workflow solutions that can transform departmental operations, advanced informatics that can provide diagnostic confidence, and care pathway solutions that allow doctors to tailor treatment to the individual patient. Philips Digital Radiography and Fluoroscopy system (CombiDiagnost R90) receives FDA 510(k) clearance At ECR 2021 Philips also announced that its Digital Radiography and Fluoroscopy system (CombiDiagnost R90), a remote controlled fluoroscopy system in combination with high-end digital radiography, has received 510(k) clearance from the U.S. Food and Drug Administration. Designed to improve room utilization in a cost effective manner. The versatile system combines a fully digital workflow, UNIQUE image quality and excellent dose management for a wide range of examinations from pediatric to bariatric imaging. Philips is showcasing its latest advances in diagnostic X-ray during the virtual ECR 2021. During the congress, Philips will host a symposium with a panel of leading physicians: ‘Smart Workflows: Improving imaging productivity and clinical confidence with AI’. For more information on Philips’ new portfolio of diagnostic and interventional solutions and AI-enabled applications to enhance radiology workflows at ECR 2021, visit the Philips ECR site, and follow @PhilipsLiveFrom for updates throughout the event. For further information, please contact: Mark GrovesPhilips Global Press OfficeTel.: +31 631 639 916E-mail: mark.groves@philips.com Kathy O’ReillyPhilips Global Press OfficeTel.: +1 978-221-8919E-mail: kathy.oreilly@philips.com About Royal Philips Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2020 sales of EUR 19.5 billion and employs approximately 82,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter. Attachments Philips Digital Radiography and Fluoroscopy system (CombiDiagnost R90) Philips Digital Radiography and Fluoroscopy system (CombiDiagnost R90) in use

  • Philips and Disney join forces to improve the healthcare experience of children
    PR Newswire

    Philips and Disney join forces to improve the healthcare experience of children

    Royal Philips (NYSE: PHG) (AEX: PHIA), a global leader in health technology, and The Walt Disney Company EMEA today announced they are teaming up to test the effects of custom-made animation , including specially-made Disney stories, within Philips Ambient Experience, a solution that integrates architecture, design and enabling technologies, such as dynamic lighting, video projections and sound, to allow patients and staff to personalize their environment to create a relaxing atmosphere. Philips' clinical research project will commence this summer in six hospitals across Europe and the results of the pilot project will be completed later this year. It is the first time Disney has collaborated as part of a clinical research project of this kind.